The synthesis and structure of a trimer 5 of the furoxan system are reported. The probable origin of this derivative is the dimerization of the intermediate 4‐phenyl‐3‐furoxancarbonitrile oxide ( 4 ) obtained by decomposition of the corresponding nitrolic acid 3 . The title compound shows a high level of activity as vasodilator and inhibitor of platelet aggregation.
No takes yet. Share an insight, caveat, or question.
Gasco et al. (1993) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: